In 2025, whooping cough—once considered nearly vanquished—has staged a disturbing resurgence across the United States. Over 35,000 cases were reported last year, a staggering 1500% increase from the post-pandemic lows observed in 2021. This sharp uptick has prompted several states to declare localized outbreaks, putting infants and vulnerable populations at grave risk. Experts attribute this resurgence primarily to declining vaccination rates and waning immunity, emphasizing the crucial importance of booster campaigns and community-wide protection.
Understanding the Pertussis Resurgence: Why Whooping Cough Is Making a Comeback
Pertussis, commonly known as whooping cough, is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. The illness begins with cold-like symptoms — a mild cough, runny nose, or low-grade fever — but rapidly escalates to intense coughing fits accompanied by a distinctive “whoop” sound upon inhalation. These coughing episodes can lead to exhaustion, vomiting, and even rib fractures. Infants under six months bear the brunt of severe complications, making this disease particularly dangerous.
The resurgence of pertussis is tightly linked to a decline in vaccination coverage. Public health data indicate that vaccination rates have slipped below the critical threshold of 92-94% needed for herd immunity. In communities where vaccines from pharmaceutical leaders like Pfizer, Sanofi, GSK, Merck, and Novartis have been underutilized, pertussis outbreaks have become increasingly prevalent. The cycle is clear:
- Lower vaccination rates weaken community protection.
- Reduced herd immunity allows for more widespread transmission.
- Vulnerable populations, especially infants and pregnant women, face heightened risk.
Waning immunity from earlier vaccine doses compounds the problem, underscoring the need for booster shots throughout adolescence and adulthood.
Pertussis Symptoms and Risks: Recognizing the Warning Signs
The initial symptoms of whooping cough often resemble a common cold, which can delay diagnosis and treatment. As the disease progresses, patients experience prolonged coughing fits that can last up to 10 weeks or more. The severity of coughing can lead to dire complications, particularly in young children and those with weakened immune systems.
- Severe coughing fits with a characteristic “whoop” sound.
- Vomiting following intense coughing episodes.
- Breathing difficulties and risk of pneumonia.
- Risk of seizures and brain damage in severe pediatric cases.
- Fatigue so extreme that eating and drinking become challenging.
With over 10 fatalities and dozens of hospitalizations reported last year, experts stress that early recognition and intervention are vital.
Vaccination: The Cornerstone of Pertussis Prevention
Vaccination remains the most effective defense against whooping cough. The Centers for Disease Control and Prevention (CDC) recommends a robust schedule to prevent infection across the lifespan. Key vaccine types include:
- DTaP — administered to children under 7 years old, combining protection against diphtheria, tetanus, and pertussis.
- Tdap — recommended for older children, adolescents, and adults as a booster to maintain immunity.
Pharmaceutical corporations like Johnson & Johnson, AstraZeneca, Moderna, Walgreens, and CVS Health play pivotal roles in vaccine distribution and community education efforts. Despite the proven safety of these vaccines and rigorous testing of adjuvants like aluminum and thimerosal, vaccine hesitancy fueled by misinformation remains a significant barrier.
Experts advise that pregnant women receive the Tdap booster between 27 and 36 weeks gestation to confer passive immunity to newborns, who are most vulnerable before completing their primary vaccine series.
Addressing Vaccine Hesitation and Access Barriers
Several factors contribute to the decline in vaccination rates:
- Complacency — the misconception that vaccine-preventable diseases are relics of the past.
- Misinformation — social media and online forums often spread inaccurate fears about vaccines.
- Access issues — economic hardship and limited healthcare reach impede timely immunization.
- Schedule confusion — many overlook the need for boosters beyond early childhood.
Healthcare providers, community pharmacies, and public health campaigns emphasize that decisions to vaccinate impact not only individuals but entire communities, especially immunocompromised persons and infants.
Strategies to Combat the Pertussis Outbreak: Building Community Immunity
Public health initiatives focus on restoring vaccination coverage to safe levels through education, outreach, and convenient access. Some effective measures include:
- Cocooning Strategy — vaccinating close contacts of newborns to form a protective buffer.
- School-based vaccination programs — targeting children and adolescents to close immunity gaps.
- Pregnancy-specific campaigns — ensuring pregnant women receive boosters in a timely manner.
- Collaboration with pharmacies — Walgreens and CVS Health facilitate easy access to boosters and immunization records.
- Clear public messaging — combatting myths and reinforcing vaccine benefits.
By raising vaccination rates above the 90% threshold, communities can thwart the spread of pertussis and protect their most vulnerable members.
Protecting Your Family: How to Stay Safe Against Whooping Cough
Parents and caregivers should:
- Ensure that children complete the full DTaP vaccination series on schedule.
- Make sure adolescents and adults receive Tdap booster shots regularly.
- Encourage pregnant women to obtain Tdap immunization during each pregnancy.
- Be vigilant for symptoms of pertussis and seek medical advice promptly if suspected.
- Consult trusted sources and healthcare providers for up-to-date vaccine information, particularly regarding providers like Pfizer, Sanofi, and Moderna.
For further guidance on health and prevention strategies, readers may find additional insights at Live Well Magazine’s wellness resources.